Amphastar Pharmaceuticals Inc. (29A)
XFRA 
Summary
29A Chart
New Strong Sell Stocks for June 23rd
ARR, AMTB and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on June 23rd, 2026.
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
Amphastar Pharmaceuticals NASDAQ: AMPH is positioning itself for a broader shift from complex generics toward proprietary medicines and biosimilars, Chief Financial Officer and Executive Vice President of Finance Bill Peters told investors at the East Coast IDEAS Conference.
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
Amphastar Pharmaceuticals NASDAQ: AMPH executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in 2026, supported by a new generic launch, Primatene Mist growth and selected API sales from its China business.
Amphastar Pharmaceuticals Inc. (29A) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Amphastar Pharmaceuticals Inc. ever had a stock split?
Amphastar Pharmaceuticals Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Yongfeng Zhang CEO | XFRA Exchange | 03209R103 CUSIP |
| US Country | 1,976 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company that focuses on the development, manufacturing, marketing, and sale of both generic and proprietary injectable, inhalation, and intranasal products. The company has a global footprint with operations in the United States, China, and France. Established in 1996 and based in Rancho Cucamonga, California, Amphastar Pharmaceuticals caters to a diverse range of medical needs, emphasizing solutions for severe hypoglycemia, opioid overdose, adrenocortical insufficiency, intermittent asthma, and deep vein thrombosis among others. Additionally, the company engages in the distribution of insulin APIs and is involved in the development of generic, biosimilar, and innovative analytical technologies.
Products and Services
- BAQSIMI - A nasal spray designed for severe hypoglycemia treatment.
- Primatene Mist - An over-the-counter epinephrine inhalation product for mild asthma symptoms.
- Enoxaparin - Used to prevent and treat deep vein thrombosis.
- REXTOVY and Naloxone - Intended for the reversal of opioid overdose.
- Glucagon Emergency Kit - A kit for injection in emergency situations to treat hypoglycemia.
- Cortrosyn - A diagnostic agent used in screening for adrenocortical insufficiency.
- Amphadase - An injection that aids the absorption and dispersion of other injected drugs.
- Epinephrine Injection - For the management of allergic reactions.
- Lidocaine Jelly and Topical Solution - Anesthetics for urological and various other procedures.
- Phytonadione Injection - A vitamin K1 injection for newborns.
- Emergency Syringe Products - Various products designed for emergency medical use.
- Morphine Injection - For use with patient-controlled analgesia pumps.
- Lorazepam Injection - Used for anxiety relief during surgery and medical procedures.
- Neostigmine Methylsulfate Injection - Treats myasthenia gravis and reverses the effects of muscle relaxants.
- Isoproterenol Hydrochloride Injection - Manages mild or transient episodes of heart block.
- Ganirelix Acetate Injection - Used for the inhibition of premature luteinizing hormone surges.
- Vasopressin - Administered to increase blood pressure in vasodilatory shock.
- Regadenoson - A stress agent used in radionuclide myocardial perfusion imaging.
- Insulin API Distribution - Distributes recombinant human and porcine insulin APIs.
- Generic Product Candidates - Focuses on developing injectable, inhalation, and analytical technologies.
- Biosimilar Product Candidates - Develops alternatives to existing biologic medicines.
- Intranasal Epinephrine - Under development for treating allergic reactions.
